Novacam 7,5 mg/ 15 mg Tablets
PDF Leaflet Revision Date: 7 July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of rheumatoid arthritis, osteoarthrosis, ankylosing spondylitis, and acute sciatica.
Dosage (summary)
15 mg/day for rheumatoid arthritis and ankylosing spondylitis; 7.5 mg/day for osteoarthrosis and acute sciatica.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Other NSAIDs
- Anticoagulants
- Corticosteroids
- Lithium
- Methotrexate
Contraindications
- Hypersensitivity to meloxicam
- Severe hepatic failure
- Severe renal failure
- Severe heart failure
- Gastrointestinal bleeding
- Active inflammatory bowel disease
- Children under 12 years
Common side effects
- Gastrointestinal disorders
- Hypertension
- Oedema
- Headache
- Dizziness
Counselling Points
- Take with food
- Monitor for gastrointestinal symptoms
- Avoid alcohol
- Report any skin reactions
Serious warnings
- Gastrointestinal bleeding risk
- Cardiovascular events risk
- Serious skin reactions
Important Disclaimer
The Novacam 7,5 mg/ 15 mg Tablets professional information leaflet below is the property of Unimed Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
